10 Rules Entrepreneurs Need to Know Before Adopting AI
Originally published in HBS Working Knowledge
![](https://fprimecapital.com/wp-content/uploads/2023/06/230516_clifford_fprime_headshots_DSF0590-square-scaled.jpg)
10 Rules Entrepreneurs Need to Know Before Adopting AI
2022 Was The Calm Before The Storm For Tech Startups
For early-stage tech investors, 2022 was the year to talk about the correction in the public markets and ensure your portfolio companies had 18-24 months of runway. As we approach the end of that runway, the realities of over-funding and over-spending are setting in.
5 Lessons Robotics Founders Can Learn From the AV Industry
6 Investment Trends That Could Emerge From the COVID-19 Pandemic
8 Fintech VCs Discuss the Shifting Investing Landscape and How to Pitch Them in Q3 2022
A Bet on Vertical Robotics
A Venture Capitalist’s Perspective on Robotics
Albert Invent’s $7.5M Seed Round
Announcing our Investment in ConnexPay
Announcing our Investment in Deal Engine
Announcing the Travel Tech Titans: Celebrating the Game-Changing Innovators in Travel
In collaboration with our colleagues at Eight Roads Ventures Europe
ARTBIO: Redefining cancer care through an entirely new class of alpha radioligand therapies (ARTs)
Assessing the State of Fintech
Behind the Breakthrough: Q&A with Emanuele Ostuni, ARTBIO
In a way, all CEOs have the same responsibilities — expanding the company, collaborating with the board, engaging stakeholders, defining strategy, and creating a positive culture. However, the way in which one approaches these tasks is a means to stand out from the crowd.
Behind the Breakthrough: Q&A with Lyn Baranowski, Avalyn Pharma
As Baranowski reflects on her career path, she notes that working in this space is the “common thread” connecting her professional experiences. Lyn began her tenure in the field at Novartis, where she first learned of less known lung diseases like pulmonary fibrosis and pulmonary hypertension.
Behind the Breakthrough: Q&A with Meena Mallipeddi, AmplifyMD
Meena Mallipeddi and her husband Anand Nathan co-founded AmplifyMD to address the limitations in healthcare access, particularly the lack of timely specialist expertise, by creating a comprehensive virtual care platform that integrates seamlessly with existing clinical workflows.
Behind the Breakthrough: Q&A with Peptone, Kamil Tamiola
Intrinsically disordered proteins (dubbed IDPs) and intrinsically disordered regions (IDRs) occur in one-third of the human proteome. Disordered proteins are shape-shifting and lack a consistent 3D structure. As a result, IDPs cannot be visualized using existing experimental methods, such as microscopy and mass spectrometry, or by predictive modeling approaches. Determined to “see” the invisible in the disordered proteome, Tamiola and his team have used interdisciplinary collaboration to address this longstanding challenge.
Behind the Breakthrough: Q&A with Stephen Smith, NOCD
Obsessive-compulsive disorder (OCD) has been ranked by the World Health Organization as a top 10 leading cause of disability, yet treatment is often misguided, as people with the condition are frequently misdiagnosed by providers.
Behind the Breakthrough: Q&A with Tammy Sun, Carrot Fertility
Inspired by her personal journey and challenges with fertility care, Tammy Sun, Founder and CEO of Carrot Fertility, established Carrot to provide inclusive fertility care and support from pre-pregnancy through menopause.
Beyond the Horror: F-Prime Report Gives Many Reasons to Love Fintech
Building the Data Integration Layer for Wealth Management
Canary Technologies: Reinventing the Hotel Tech Stack
F-Prime’s Summer Internship and Fellowship Program: Meet Our 2024 Interns and Fellows
This summer, F-Prime was excited to welcome a talented group of interns and fellows to our Cambridge office. They played key roles in competitive landscape analysis, sourcing, founder calls, and more. Read on to discover what it's like to be part of our internship and fellowship programs.
F-Prime’s Summer Internship Program: Meet our 2023 interns and fellows
Fintech Is Operating at Scale, With Huge Growth Potential
Fintech’s Great Reappraisal
For LatAm Payment Orchestration Startups, Market Fragmentation Is a Blessing in Disguise
Founders Diaries: The stories keep getting better….
From Surge to Sobriety: The State of Robotics Investment in 2024
Future Of Financial Advice – More Co-Pilot Than Autopilot
Generational Shifts Drive New Fintech Innovation and Investment
Healthcare is the next wave of data liberation
Hone: HR’s Secret Weapon
How Fintech Is Disrupting Traditional Banks in 2024
In sectors like mobile banking and commission-free trading, fintech companies have had a profound on financial incumbents. In other areas, the future of banking and fintech is still being developed.
How Startups Can Help You Win the Talent War With Tailored Employee Benefits
In Fintech, 2023 Was the Year of “Regulation On, Risk Off”
Influencers Are a New Class of Travel Agents — But Lack the Right Tools
Introducing Ashby: The Data-Driven ATS
Key Takeaways from Robotics Invest 2023
Co-authored with Fady Saad of Cybernetix Ventures
LatAm Payments and Banking Outperform F-Prime Fintech Index
Latchel: The Operating System for Property Management
Leading Mathison’s Series A to become the First All-In-One DEI Operating System
New Digital Care Architecture: The “Four Ds of Digital Health” Meet the “Two As of Automation”
A new digital care architecture is transforming healthcare by integrating the Three Ds of healthcare delivery (doctors, drugs, and diagnostics) with data, AI, and API-based services, creating a more accessible, personalized, and efficient system for both patients and providers.
Pioneering Progress: The FARAPULSE™ Story
F-Prime is dedicated to advancing pioneering science and technologies that redefine patient care and treatment. Since 2002, F-Prime has facilitated the regulatory approval and commercialization of 33 products and drugs. In our new series, Pioneering Progress, we will be showcasing success stories behind the approval of drugs and products from our portfolio companies.
Pioneering Progress: The Lenmeldy™ Story
F-Prime is dedicated to advancing pioneering science and technologies that redefine patient care. Since 2002, F-Prime has facilitated the regulatory approval and commercialization of 33 products and drugs. In our series, Pioneering Progress, we will be showcasing the success stories behind the approval of drugs and products from our portfolio companies.
Retooling the Lab-Software Stack
Robotics – Has the Time Finally Arrived for Venture Capital?
Software Buying Has Changed Forever
State of Robotics in 2024: The Rise of Vertical Robotics
Tapping into the future of warehouse robotics — Part 1
Tapping into the future of warehouse robotics — Part 2
Technologies Enabling the Future of Robotics
The 2024 State of Fintech Report
The Alternative Asset Class Needs New Infrastructure — Who Will Build It?
The Four Ds of Digital Health
Unlike conventional stakeholder-centric models, the Four Ds zero in on the essential functions individuals seek from healthcare: accessing the right mix of professionals, medications, and tests. However, a glaring obstacle obstructs progress: the sorry state of healthcare data.
The Next Wave of Autonomous Vehicles
The RTP Gold Rush: 10 FedNow Predictions
The State of Banking Report
There Are Gaps In The US Real-Time Payment System. Who Will Fill Them?
These Startups Are Helping Employers Prepare for the Post-COVID Workplace
Toast, the Restaurant Industry and an Exceptional Case for Vertical Payments
Toku Takes Flight: Revolutionizing Recurring Revenue Collection in LatAm
Tracking the Disruptors With The F-Prime Fintech Index
Tracking the Industry Rebound with the F-Prime Fintech Index
Travel Tech’s Startup Moment, Pt. 1: Modernizing the Hotel Stack
Video Interview: Exploring the State of Fintech with NYSE Floor Talk
Video Interview: Indexing for the Fintech Space
Video Interview: The State of Fintech and Why We Can Expect Significant M&A in the Space for 2023
Video Interview: The State of Robotics report
What Founders Need to Know Before Selling Their Startup
Who Will Build the Bloomberg of Private Markets Data?
Why SaaS Vendors Must Embrace Zero-Copy Data Sharing to Stay Competitive
Why We Invested in Carrot Fertility: A global leader in fertility healthcare and family-forming
Will China’s Coronavirus-Related Trends Shape the Future for American VCs?